APA

Dirix P., Strijbos M., den Mooter T. V., Liefhooghe N., Bruwaene S. V., Uvin P., Ghysel C., Ost D., Schatteman P., Bral S., Engels B., den Begin R. V., Otte F., Roumeguere T., Palumbo S., Neybuch Y., Fonteyne V., Ost P. & Dirix L. (20210317). Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy. : Future oncology (London, England).

Chicago

Dirix Piet, Strijbos Michiel, den Mooter Tom Van, Liefhooghe Nick, Bruwaene Siska Van, Uvin Pieter, Ghysel Christophe, Ost Dieter, Schatteman Peter, Bral Samuel, Engels Benedikt, den Begin Robbe Van, Otte François-Xavier, Roumeguere Thierry, Palumbo Samuel, Neybuch Yannick, Fonteyne Valérie, Ost Piet and Dirix Luc. 20210317. Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy. : Future oncology (London, England).

Harvard

Dirix P., Strijbos M., den Mooter T. V., Liefhooghe N., Bruwaene S. V., Uvin P., Ghysel C., Ost D., Schatteman P., Bral S., Engels B., den Begin R. V., Otte F., Roumeguere T., Palumbo S., Neybuch Y., Fonteyne V., Ost P. and Dirix L. (20210317). Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy. : Future oncology (London, England).

MLA

Dirix Piet, Strijbos Michiel, den Mooter Tom Van, Liefhooghe Nick, Bruwaene Siska Van, Uvin Pieter, Ghysel Christophe, Ost Dieter, Schatteman Peter, Bral Samuel, Engels Benedikt, den Begin Robbe Van, Otte François-Xavier, Roumeguere Thierry, Palumbo Samuel, Neybuch Yannick, Fonteyne Valérie, Ost Piet and Dirix Luc. Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy. : Future oncology (London, England). 20210317.